- Home
- DAWN vs VIRT Comparison
DAWN vs VIRT Comparison
Compare DAWN & VIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- VIRT
- Stock Information
- Founded
- DAWN 2018
- VIRT 2008
- Country
- DAWN United States
- VIRT United States
- Employees
- DAWN N/A
- VIRT N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- VIRT Investment Bankers/Brokers/Service
- Sector
- DAWN Health Care
- VIRT Finance
- Exchange
- DAWN Nasdaq
- VIRT Nasdaq
- Market Cap
- DAWN 658.9M
- VIRT 3.3B
- IPO Year
- DAWN 2021
- VIRT 2015
- Fundamental
- Price
- DAWN $7.02
- VIRT $43.99
- Analyst Decision
- DAWN Strong Buy
- VIRT Hold
- Analyst Count
- DAWN 7
- VIRT 8
- Target Price
- DAWN $31.57
- VIRT $37.25
- AVG Volume (30 Days)
- DAWN 1.3M
- VIRT 808.3K
- Earning Date
- DAWN 07-29-2025
- VIRT 07-30-2025
- Dividend Yield
- DAWN N/A
- VIRT 2.18%
- EPS Growth
- DAWN N/A
- VIRT 142.03
- EPS
- DAWN N/A
- VIRT 3.46
- Revenue
- DAWN $161,922,000.00
- VIRT $2,401,575,000.00
- Revenue This Year
- DAWN $17.98
- VIRT N/A
- Revenue Next Year
- DAWN $49.50
- VIRT N/A
- P/E Ratio
- DAWN N/A
- VIRT $12.71
- Revenue Growth
- DAWN N/A
- VIRT 43.16
- 52 Week Low
- DAWN $6.08
- VIRT $22.34
- 52 Week High
- DAWN $16.76
- VIRT $45.12
- Technical
- Relative Strength Index (RSI)
- DAWN 58.34
- VIRT 57.16
- Support Level
- DAWN $6.52
- VIRT $42.53
- Resistance Level
- DAWN $7.24
- VIRT $45.12
- Average True Range (ATR)
- DAWN 0.26
- VIRT 0.98
- MACD
- DAWN 0.07
- VIRT -0.06
- Stochastic Oscillator
- DAWN 78.37
- VIRT 67.53
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
About VIRT Virtu Financial Inc.
Virtu Financial Inc is a financial firm that leverages cutting edge technology to deliver liquidity to the global markets and innovative, transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.